Viral Safety Testing in Biologics: Detecting What Current Methods Miss

This webinar breaks down how evolving expectations under ICH Q5A(R2) are reshaping viral detection strategies, shifting the industry from targeted testing toward broader, more sensitive approaches. Through real‑world examples, you’ll learn where current methods fall short, how newer technologies expand visibility, and how teams can strengthen viral safety programs without disrupting development timelines or regulatory alignment.

Watch the discussion to learn how to modernize viral safety testing and uncover what traditional methods may be missing.